Another step toward new drugs for Parkinson’s

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning, everyone. Damian here with the plight of the venture capitalist, an idea for Gilead Sciences, and the latest in the quest to find potent treatments for Parkinson’s disease.

The need-to-know this morning

• Cancer drug developer CG Oncology raised $380 million in an initial public offering. It’s the first biotech IPO of 2024.

Biotech VCs are feeling the squeeze

As fledgling drug companies struggle to raise the cash they need to survive, spare a moment for the venture capitalists on the other side of the Zoom screen.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

Log In